Novartis AG (NVSEF)
127.40
+0.78
(+0.62%)
USD |
OTCM |
Dec 11, 14:10
Novartis Profit Margin (Quarterly): 28.26% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Roche Holding AG | -- |
| BeOne Medicines Ltd. | 8.84% |
| AC Immune SA | -1.69K% |
| CRISPR Therapeutics AG | -11.97K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 33.79% |
| Return on Assets | 13.78% |
| Return on Invested Capital | 19.32% |
| Gross Profit Margin (Quarterly) | 74.58% |
| Operating Margin (Quarterly) | 30.24% |
| Return on Net Operating Assets | 18.14% |